世界のサラセミア市場2020:企業別、地域別、種類・用途別

【英語タイトル】Global Thalassemia Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20MY15788)・商品コード:GIR20MY15788
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年5月(※2024年版があります。お問い合わせください)
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、サラセミアの世界市場を広く調査・分析し、今後の市場展望をまとめております。サラセミアの種類別市場規模(鉄キレート剤、その他)、用途別市場規模(病院、クリニック、研究所、実験室)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Bluebird bio, Inc.、La Jolla Pharmaceutical Company、GlaxoSmithKline plc、Acceleron Pharma, Inc.、Kiadis Pharma、Celgene Corporation、Gamida Cell、Incyte Corporation、IONIS Pharmaceuticals
・地域別グローバル市場分析 2015年-2020年
・サラセミアの北米市場(アメリカ、カナダ、メキシコ)
・サラセミアのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・サラセミアのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・サラセミアの南米市場(ブラジル、アルゼンチン)
・サラセミアの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:鉄キレート剤、その他
・用途別分析:病院、クリニック、研究所、実験室
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Thalassemia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Thalassemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Thalassemia market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Thalassemia market has been segmented into:
Iron Chelating Drugs
Others

By Application, Thalassemia has been segmented into:
Hospital
Clinic
Research Institute
Laboratories

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Thalassemia market presented in the report. This section sheds light on the sales growth of different regional and country-level Thalassemia markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Thalassemia market.

The report offers in-depth assessment of the growth and other aspects of the Thalassemia market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Thalassemia Market Share Analysis
Thalassemia competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Thalassemia sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Thalassemia sales, revenue and market share for each player covered in this report.

The major players covered in Thalassemia are:
Bluebird bio, Inc.
La Jolla Pharmaceutical Company
GlaxoSmithKline plc
Acceleron Pharma, Inc.
Kiadis Pharma
Celgene Corporation
Gamida Cell
Incyte Corporation
IONIS Pharmaceuticals

【レポートの目次】

Table of Contents

1 Thalassemia Market Overview
1.1 Product Overview and Scope of Thalassemia
1.2 Classification of Thalassemia by Type
1.2.1 Global Thalassemia Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Thalassemia Revenue Market Share by Type in 2019
1.2.3 Iron Chelating Drugs
1.2.4 Others
1.3 Global Thalassemia Market by Application
1.3.1 Overview: Global Thalassemia Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.4 Global Thalassemia Market by Regions
1.4.1 Global Thalassemia Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Thalassemia (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Thalassemia Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Thalassemia Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Thalassemia Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Thalassemia Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Thalassemia Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bluebird bio, Inc.
2.1.1 Bluebird bio, Inc. Details
2.1.2 Bluebird bio, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bluebird bio, Inc. SWOT Analysis
2.1.4 Bluebird bio, Inc. Product and Services
2.1.5 Bluebird bio, Inc. Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.2 La Jolla Pharmaceutical Company
2.2.1 La Jolla Pharmaceutical Company Details
2.2.2 La Jolla Pharmaceutical Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 La Jolla Pharmaceutical Company SWOT Analysis
2.2.4 La Jolla Pharmaceutical Company Product and Services
2.2.5 La Jolla Pharmaceutical Company Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline plc
2.3.1 GlaxoSmithKline plc Details
2.3.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline plc SWOT Analysis
2.3.4 GlaxoSmithKline plc Product and Services
2.3.5 GlaxoSmithKline plc Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.4 Acceleron Pharma, Inc.
2.4.1 Acceleron Pharma, Inc. Details
2.4.2 Acceleron Pharma, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Acceleron Pharma, Inc. SWOT Analysis
2.4.4 Acceleron Pharma, Inc. Product and Services
2.4.5 Acceleron Pharma, Inc. Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kiadis Pharma
2.5.1 Kiadis Pharma Details
2.5.2 Kiadis Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kiadis Pharma SWOT Analysis
2.5.4 Kiadis Pharma Product and Services
2.5.5 Kiadis Pharma Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene Corporation SWOT Analysis
2.6.4 Celgene Corporation Product and Services
2.6.5 Celgene Corporation Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gamida Cell
2.7.1 Gamida Cell Details
2.7.2 Gamida Cell Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gamida Cell SWOT Analysis
2.7.4 Gamida Cell Product and Services
2.7.5 Gamida Cell Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.8 Incyte Corporation
2.8.1 Incyte Corporation Details
2.8.2 Incyte Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Incyte Corporation SWOT Analysis
2.8.4 Incyte Corporation Product and Services
2.8.5 Incyte Corporation Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.9 IONIS Pharmaceuticals
2.9.1 IONIS Pharmaceuticals Details
2.9.2 IONIS Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 IONIS Pharmaceuticals SWOT Analysis
2.9.4 IONIS Pharmaceuticals Product and Services
2.9.5 IONIS Pharmaceuticals Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Thalassemia Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Thalassemia Players Market Share
3.2.2 Top 10 Thalassemia Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Thalassemia Revenue and Market Share by Regions
4.2 North America Thalassemia Revenue and Growth Rate (2015-2020)
4.3 Europe Thalassemia Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Thalassemia Revenue and Growth Rate (2015-2020)
4.5 South America Thalassemia Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Thalassemia Revenue and Growth Rate (2015-2020)
5 North America Thalassemia Revenue by Countries
5.1 North America Thalassemia Revenue by Countries (2015-2020)
5.2 USA Thalassemia Revenue and Growth Rate (2015-2020)
5.3 Canada Thalassemia Revenue and Growth Rate (2015-2020)
5.4 Mexico Thalassemia Revenue and Growth Rate (2015-2020)
6 Europe Thalassemia Revenue by Countries
6.1 Europe Thalassemia Revenue by Countries (2015-2020)
6.2 Germany Thalassemia Revenue and Growth Rate (2015-2020)
6.3 UK Thalassemia Revenue and Growth Rate (2015-2020)
6.4 France Thalassemia Revenue and Growth Rate (2015-2020)
6.5 Russia Thalassemia Revenue and Growth Rate (2015-2020)
6.6 Italy Thalassemia Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Thalassemia Revenue by Countries
7.1 Asia-Pacific Thalassemia Revenue by Countries (2015-2020)
7.2 China Thalassemia Revenue and Growth Rate (2015-2020)
7.3 Japan Thalassemia Revenue and Growth Rate (2015-2020)
7.4 Korea Thalassemia Revenue and Growth Rate (2015-2020)
7.5 India Thalassemia Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Thalassemia Revenue and Growth Rate (2015-2020)
8 South America Thalassemia Revenue by Countries
8.1 South America Thalassemia Revenue by Countries (2015-2020)
8.2 Brazil Thalassemia Revenue and Growth Rate (2015-2020)
8.3 Argentina Thalassemia Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Thalassemia by Countries
9.1 Middle East & Africa Thalassemia Revenue by Countries (2015-2020)
9.2 Saudi Arabia Thalassemia Revenue and Growth Rate (2015-2020)
9.3 UAE Thalassemia Revenue and Growth Rate (2015-2020)
9.4 Egypt Thalassemia Revenue and Growth Rate (2015-2020)
9.5 South Africa Thalassemia Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Thalassemia Revenue and Market Share by Type (2015-2020)
10.2 Global Thalassemia Market Forecast by Type (2019-2024)
10.3 Iron Chelating Drugs Revenue Growth Rate (2015-2025)
10.4 Others Revenue Growth Rate (2015-2025)
11 Global Thalassemia Market Segment by Application
11.1 Global Thalassemia Revenue Market Share by Application (2015-2020)
11.2 Thalassemia Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Research Institute Revenue Growth (2015-2020)
11.6 Laboratories Revenue Growth (2015-2020)
12 Global Thalassemia Market Size Forecast (2021-2025)
12.1 Global Thalassemia Market Size Forecast (2021-2025)
12.2 Global Thalassemia Market Forecast by Regions (2021-2025)
12.3 North America Thalassemia Revenue Market Forecast (2021-2025)
12.4 Europe Thalassemia Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Thalassemia Revenue Market Forecast (2021-2025)
12.6 South America Thalassemia Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Thalassemia Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Thalassemia Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Thalassemia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Thalassemia Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Thalassemia Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bluebird bio, Inc. Corporate Information, Location and Competitors
Table 6. Bluebird bio, Inc. Thalassemia Major Business
Table 7. Bluebird bio, Inc. Thalassemia Total Revenue (USD Million) (2017-2018)
Table 8. Bluebird bio, Inc. SWOT Analysis
Table 9. Bluebird bio, Inc. Thalassemia Product and Solutions
Table 10. Bluebird bio, Inc. Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. La Jolla Pharmaceutical Company Corporate Information, Location and Competitors
Table 12. La Jolla Pharmaceutical Company Thalassemia Major Business
Table 13. La Jolla Pharmaceutical Company Thalassemia Total Revenue (USD Million) (2018-2019)
Table 14. La Jolla Pharmaceutical Company SWOT Analysis
Table 15. La Jolla Pharmaceutical Company Thalassemia Product and Solutions
Table 16. La Jolla Pharmaceutical Company Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GlaxoSmithKline plc Corporate Information, Location and Competitors
Table 18. GlaxoSmithKline plc Thalassemia Major Business
Table 19. GlaxoSmithKline plc Thalassemia Total Revenue (USD Million) (2017-2018)
Table 20. GlaxoSmithKline plc SWOT Analysis
Table 21. GlaxoSmithKline plc Thalassemia Product and Solutions
Table 22. GlaxoSmithKline plc Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Acceleron Pharma, Inc. Corporate Information, Location and Competitors
Table 24. Acceleron Pharma, Inc. Thalassemia Major Business
Table 25. Acceleron Pharma, Inc. Thalassemia Total Revenue (USD Million) (2017-2018)
Table 26. Acceleron Pharma, Inc. SWOT Analysis
Table 27. Acceleron Pharma, Inc. Thalassemia Product and Solutions
Table 28. Acceleron Pharma, Inc. Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Kiadis Pharma Corporate Information, Location and Competitors
Table 30. Kiadis Pharma Thalassemia Major Business
Table 31. Kiadis Pharma Thalassemia Total Revenue (USD Million) (2017-2018)
Table 32. Kiadis Pharma SWOT Analysis
Table 33. Kiadis Pharma Thalassemia Product and Solutions
Table 34. Kiadis Pharma Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Celgene Corporation Corporate Information, Location and Competitors
Table 36. Celgene Corporation Thalassemia Major Business
Table 37. Celgene Corporation Thalassemia Total Revenue (USD Million) (2017-2018)
Table 38. Celgene Corporation SWOT Analysis
Table 39. Celgene Corporation Thalassemia Product and Solutions
Table 40. Celgene Corporation Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Gamida Cell Corporate Information, Location and Competitors
Table 42. Gamida Cell Thalassemia Major Business
Table 43. Gamida Cell Thalassemia Total Revenue (USD Million) (2017-2018)
Table 44. Gamida Cell SWOT Analysis
Table 45. Gamida Cell Thalassemia Product and Solutions
Table 46. Gamida Cell Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Incyte Corporation Corporate Information, Location and Competitors
Table 48. Incyte Corporation Thalassemia Major Business
Table 49. Incyte Corporation Thalassemia Total Revenue (USD Million) (2017-2018)
Table 50. Incyte Corporation SWOT Analysis
Table 51. Incyte Corporation Thalassemia Product and Solutions
Table 52. Incyte Corporation Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. IONIS Pharmaceuticals Corporate Information, Location and Competitors
Table 54. IONIS Pharmaceuticals Thalassemia Major Business
Table 55. IONIS Pharmaceuticals Thalassemia Total Revenue (USD Million) (2017-2018)
Table 56. IONIS Pharmaceuticals SWOT Analysis
Table 57. IONIS Pharmaceuticals Thalassemia Product and Solutions
Table 58. IONIS Pharmaceuticals Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Thalassemia Revenue (Million USD) by Players (2015-2020)
Table 60. Global Thalassemia Revenue Share by Players (2015-2020)
Table 61. Global Thalassemia Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Thalassemia Revenue Market Share by Regions (2015-2020)
Table 63. North America Thalassemia Revenue by Countries (2015-2020)
Table 64. North America Thalassemia Revenue Market Share by Countries (2015-2020)
Table 65. Europe Thalassemia Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Thalassemia Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Thalassemia Revenue by Countries (2015-2020)
Table 68. South America Thalassemia Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Thalassemia Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Thalassemia Revenue Market Share by Countries (2015-2020)
Table 71. Global Thalassemia Revenue (Million USD) by Type (2015-2020)
Table 72. Global Thalassemia Revenue Share by Type (2015-2020)
Table 73. Global Thalassemia Revenue Forecast by Type (2021-2025)
Table 74. Global Thalassemia Revenue by Application (2015-2020)
Table 75. Global Thalassemia Revenue Share by Application (2015-2020)
Table 76. Global Thalassemia Revenue Forecast by Application (2021-2025)
Table 77. Global Thalassemia Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Thalassemia Picture
Figure 2. Global Thalassemia Revenue Market Share by Type in 2019
Figure 3. Iron Chelating Drugs Picture
Figure 4. Others Picture
Figure 5. Thalassemia Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Research Institute Picture
Figure 9. Laboratories Picture
Figure 10. Global Thalassemia Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Thalassemia Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Thalassemia Revenue Market Share in 2019
Figure 19. Global Top 10 Players Thalassemia Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Thalassemia Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Thalassemia Revenue Market Share by Regions (2015-2020)
Figure 23. Global Thalassemia Revenue Market Share by Regions in 2018
Figure 24. North America Thalassemia Revenue and Growth Rate (2015-2020)
Figure 25. Europe Thalassemia Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Thalassemia Revenue and Growth Rate (2015-2020)
Figure 27. South America Thalassemia Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Thalassemia Revenue and Growth Rate (2015-2020)
Figure 29. North America Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 30. North America Thalassemia Revenue Market Share by Countries in 2019
Figure 31. USA Thalassemia Revenue and Growth Rate (2015-2020)
Figure 32. Canada Thalassemia Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Thalassemia Revenue and Growth Rate (2015-2020)
Figure 34. Europe Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Thalassemia Revenue Market Share by Countries in 2019
Figure 36. Germany Thalassemia Revenue and Growth Rate (2015-2020)
Figure 37. UK Thalassemia Revenue and Growth Rate (2015-2020)
Figure 38. France Thalassemia Revenue and Growth Rate (2015-2020)
Figure 39. Russia Thalassemia Revenue and Growth Rate (2015-2020)
Figure 40. Italy Thalassemia Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Thalassemia Revenue Market Share by Countries in 2019
Figure 43. China Thalassemia Revenue and Growth Rate (2015-2020)
Figure 44. Japan Thalassemia Revenue and Growth Rate (2015-2020)
Figure 45. Korea Thalassemia Revenue and Growth Rate (2015-2020)
Figure 46. India Thalassemia Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Thalassemia Revenue and Growth Rate (2015-2020)
Figure 48. South America Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 49. South America Thalassemia Revenue Market Share by Countries in 2019
Figure 50. Brazil Thalassemia Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Thalassemia Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Thalassemia Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Thalassemia Revenue and Growth Rate (2015-2020)
Figure 55. UAE Thalassemia Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Thalassemia Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Thalassemia Revenue and Growth Rate (2015-2020)
Figure 58. Global Thalassemia Revenue Share by Type (2015-2020)
Figure 59. Global Thalassemia Revenue Share by Type in 2019
Figure 60. Global Thalassemia Market Share Forecast by Type (2021-2025)
Figure 61. Global Iron Chelating Drugs Revenue Growth Rate (2015-2020)
Figure 62. Global Others Revenue Growth Rate (2015-2020)
Figure 63. Global Thalassemia Revenue Share by Application (2015-2020)
Figure 64. Global Thalassemia Revenue Share by Application in 2019
Figure 65. Global Thalassemia Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Clinic Revenue Growth Rate (2015-2020)
Figure 68. Global Research Institute Revenue Growth Rate (2015-2020)
Figure 69. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 70. Global Thalassemia Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Thalassemia Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Thalassemia Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Thalassemia Revenue Market Forecast (2021-2025)
Figure 74. Europe Thalassemia Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Thalassemia Revenue Market Forecast (2021-2025)
Figure 76. South America Thalassemia Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Thalassemia Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Bluebird bio, Inc.、La Jolla Pharmaceutical Company、GlaxoSmithKline plc、Acceleron Pharma, Inc.、Kiadis Pharma、Celgene Corporation、Gamida Cell、Incyte Corporation、IONIS Pharmaceuticals

★調査レポート[世界のサラセミア市場2020:企業別、地域別、種類・用途別] (コード:GIR20MY15788)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のサラセミア市場2020:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆